Predicting P-glycoprotein substrates by a quantitative structure–activity relationship model
Vijay K. Gombar, Joseph W. Polli, Joan E. Humphreys et al. · Journal of Pharmaceutical Sciences · 2004
Cited by 112 works. doi:10.1002/jps.20035
Authors
References
- Drug-like properties and the causes of poor solubility and poor permeability
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.
- Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
- Mammalian ABC Transporters in Health and Disease
- The electrotopological state: structure information at the atomic level for molecular graphs
- Molecular Structure Description: The Electrotopological State
- Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
- Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
- Role of P-Glycoprotein in Pharmacokinetics
- Rational Use of in Vitro P-glycoprotein Assays in Drug Discovery